🔎 Trials Near Me

Utama › Kolitis Ulseratif › Missouri › St. Louis

Kajian klinikal Kolitis Ulseratif di St. Louis, MO

13 kajian untuk Kolitis Ulseratif sedang mencari peserta di lokasi dalam dan sekitar St. Louis (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Mengambil pesertaFasa 2
  • Specialists In Gastroenterology /ID# 283939, St Louis
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Mengambil pesertaFasa 4
  • SSM Health Medical Group, Bridgeton · 15 mi jauh
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 2
  • Site US-006, St Louis
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07845487

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Mengambil pesertaFasa 2/3
  • Washington University, St Louis
Umur 2 hingga 17 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Mengambil pesertaFasa 3
  • Washington University School of Medicine, St Louis
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Mengambil pesertaFasa 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Mengambil pesertaFasa 2
  • Center for Gastrointestinal Health - Fairview Heights, Belleville · 14 mi jauh
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07186101

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Mengambil pesertaFasa 2
  • KAD Clinical Research, St Louis
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Mengambil pesertaFasa 3
  • Washington University School of Medicine, St Louis
Umur 2 hingga 19 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04844606

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 2
  • KAD Clinical Research, St Louis
  • Specialists in Gastroenterology, St Louis
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Mengambil pesertaFasa 4
  • Washington University School of Medicine, St Louis
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06095128

BOOM-IBD2 Pivotal Clinical Trial

Mengambil peserta
  • Gateway GI Research (Objective Health), St Louis
Umur 18 hingga 85 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06571669

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mengambil pesertaFasa 2
  • Mirador Therapeutics Selected Site, Bridgeton · 15 mi jauh
Umur 18 hingga 80 · Semua jantina · Dikemas kini 12 Mac 2026 · NCT07113522

Kajian Kolitis Ulseratif di bandar lain

Kajian lain di St. Louis

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.